The Franca Fund Gala
-
Event date 23 NOV -
Event location DOHA
This extraordinary evening, hosted by H.E. Sheikha Al Mayassa bint Hamad bin Khalifa Al-Thani, Anna Wintour and Francesco Carrozzini, will honor Franca Sozzani’s enduring legacy while championing the transformative power of science and preventive medicine.
All proceeds from the event will support The Franca Fund, which has been a steadfast partner of Dr. Robert Green at Harvard, advancing pioneering research in preventive genomic medicine—a field with the potential to revolutionise healthcare by predicting and preventing disease before it begins. The fundraising mission is to establish a permanent Endowed Professorship in Preventive Genomics at Harvard, ensuring that Franca Sozzani’s impact continues for generations to come.
Christie’s is proud to support the event and provide an auctioneer for the live auction hosted by Qatar Museums.
Enquiries
About
M7
Established by Qatar Museums under the leadership of its Chairperson, Her Excellency Sheikha Al Mayassa bint Hamad bin Khalifa Al Thani, M7 is Qatar’s epicenter for innovation in fashion, design, and technology.
M7 drives growth of Qatar’s creative economy, with an emphasis on fashion design, by offering the resources, opportunities, and platforms for designers to succeed locally and internationally. Its platforms include mentorship programmes, exhibitions, pop-ups, and public events. Located in Msheireb Downtown Doha, M7 is a dynamic space for creatives of all levels and works with its Resident Partners, The Cutting Studio, Studio 7, Scale 7, Fromm, and Workinton amongst others. Previous exhibitions include ‘Masterpieces of Furniture Design’ (2023), ‘Forever Valentino’ (2022), and ‘Christian Dior: Designer of Dreams’ (2021). It is home to the Design Doha Biennale, Tasweer Photography Festival, and Fashion Trust Arabia.
M7 serves to:
- advance the careers of local creatives, with a focus on fashion and design
- Train aspiring entrepreneurs in creative fields. Spark creativity through exhibitions, educational and skill-based programmes, and public discussions connect Qatar’s creative innovators with the world.
Beginning in 2025, Qatar will mark its 50-year cultural journey with Evolution Nation, an 18-month celebration of the nation’s cultural milestones and future aspirations. Curated by Qatar Creates, this positions Qatar as a global hub for art, culture, and creativity.
The Franca Fund
The Franca Sozzani Fund for Preventive Genomics is a research and advocacy organization dedicated to advancing the study and implementation of preventative genomics. Its mission is to ensure that everyone, regardless of ethnicity or socioeconomic background, may benefit from cutting-edge personalized medical treatments for a variety of health concerns.
The Franca Fund was established in 2018 by filmmaker Francesco Carrozzini, recording artist and investor D.A. Wallach, and Dr. Robert Green, an internationally acclaimed medical geneticist and physician-scientist. As a tribute to Franca Sozzani’s visionary spirit and commitment to humanitarianism, the Fund is at the forefront of science, medicine and philanthropy. It supports the use of genomic data to help predict and prevent diseases before symptoms arise, with a focus on underserved communities that have historically been excluded from such innovation. Together, The Franca Fund and Dr. Green’s team are reimagining how we approach healthcare with a powerful blend of science, ethics and advocacy.
Dr. Robert Green
Robert Green, MD, MPH completed his undergraduate studies at Amherst College, earned his MD from the University of Virginia School of Medicine, and received an MPH in epidemiology from Emory University. He completed residency training at Harvard Medical School and is board certified in both neurology and medical genetics.
He is currently a professor of medicine at Harvard Medical School and directs the Genomes2People (G2P) Research Program, the Preventive Genomics Clinic and the Population Precision Health initiative at Mass General Brigham, Broad Institute and Ariadne Labs. His pioneering efforts are at the forefront of using DNA analysis (“genomics”) to find hidden health risks and prevent disease in both adults and children, paving the way for the medical field to transform from reactive to preventive. Through rigorous scientific research, G2P is establishing a foundation of evidence for genomic medicine that will accelerate the adoption of novel genomics-based technologies, model new approaches to care, and explore ways for patients, physicians and consumers to use genomic information to achieve improved health and longevity.
Dr. Green and his team are currently focused on the BabySeq Project, the NIH-funded initiative and the world’s first to introduce comprehensive DNA sequencing for apparently healthy infants which has published extensively on medical benefits, psychosocial outcomes and medical costs associated with newborn and childhood sequencing.